Rivaroxaban: Lancet is under pressure to retract “unreliable” paper as investigation drags on
Nineteen months after an investigation was promised into a trial of the anticlotting drug rivaroxaban,1…
Category: Surgery, Data campaign
Nineteen months after an investigation was promised into a trial of the anticlotting drug rivaroxaban,1…